Control of the heparosan N-deacetylation leads to an improved bioengineered heparin

[1]  R. Linhardt,et al.  E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor , 2010, Biotechnology and bioengineering.

[2]  Haiying Liu,et al.  Lessons learned from the contamination of heparin. , 2009, Natural product reports.

[3]  Jesús Jiménez-Barbero,et al.  Solution structures of chemoenzymatically synthesized heparin and its precursors. , 2008, Journal of the American Chemical Society.

[4]  R. Langer,et al.  Contaminated heparin associated with adverse clinical events and activation of the contact system. , 2008, The New England journal of medicine.

[5]  Robert Langer,et al.  Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events , 2008, Nature Biotechnology.

[6]  C. Larive,et al.  Ultraperformance ion-pair liquid chromatography coupled to electrospray time-of-flight mass spectrometry for compositional profiling and quantification of heparin and heparan sulfate. , 2008, Analytical chemistry.

[7]  Jian Liu,et al.  Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures. , 2007, Chemistry & biology.

[8]  Robert J Linhardt,et al.  Enzymatic Redesigning of Biologically Active Heparan Sulfate* , 2005, Journal of Biological Chemistry.

[9]  M. Salmivirta,et al.  Generation of "neoheparin" from E. coli K5 capsular polysaccharide. , 2005, Journal of medicinal chemistry.

[10]  F. Maccari,et al.  Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site. , 2004, Glycobiology.

[11]  R. Linhardt,et al.  Heparin-Binding Domains in Vascular Biology , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[12]  Zhengliang L. Wu,et al.  Chemoenzymatic Synthesis of Classical and Non-classical Anticoagulant Heparan Sulfate Polysaccharides* , 2003, Journal of Biological Chemistry.

[13]  Balagurunathan Kuberan,et al.  Enzymatic synthesis of antithrombin III–binding heparan sulfate pentasaccharide , 2003, Nature Biotechnology.

[14]  R. Linhardt.  2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity. , 2003, Journal of medicinal chemistry.

[15]  G. Torri,et al.  Combined Quantitative 1H and 13C Nuclear Magnetic Resonance Spectroscopy for Characterization of Heparin Preparations , 2001, Seminars in thrombosis and hemostasis.

[16]  J. J. Schwartz,et al.  The Effect of Precursor Structures on the Action of Glucosaminyl 3-O-Sulfotransferase-1 and the Biosynthesis of Anticoagulant Heparan Sulfate* , 2001, The Journal of Biological Chemistry.

[17]  U. Lindahl.  ‘Heparin’ – from anticoagulant drug into the new biology , 2000, Glycoconjugate Journal.

[18]  J. Herbert,et al.  Synthesis of thrombin-inhibiting heparin mimetics without side effects , 1999, Nature.

[19]  A. Iorio,et al.  Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. , 1998, The New England journal of medicine.

[20]  Houdenhoven Francois Egber Van,et al.  A process for the preparation of heparin , 1998 .

[21]  Z. Witczak,et al.  Carbohydrates in Drug Design , 1997 .

[22]  N. Razi,et al.  Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5. , 1994 .

[23]  U. Lindahl,et al.  Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions. , 1991, The Biochemical journal.

[24]  R. Linhardt,et al.  Structural variation in the antithrombin III binding site region and its occurrence in heparin from different sources. , 1990, Biochemistry.

[25]  R. Linhardt,et al.  Mapping and quantification of the major oligosaccharide components of heparin. , 1988, The Biochemical journal.

[26]  I. Pettersson,et al.  Biosynthesis of heparin , 1986, Glycoconjugate Journal.

[27]  B. Lindberg,et al.  A new method for the N-deacetylation of carbohydrates , 1976 .

[28]  R. Linhardt,et al.  Analysis of E. coli K5 capsular polysaccharide heparosan , 2011, Analytical and bioanalytical chemistry.

[29]  P. Dubin,et al.  Determination of molecular weight of heparin by size exclusion chromatography with universal calibration. , 2003, Analytical biochemistry.

[30]  B. Casu,et al.  Structure and biological interactions of heparin and heparan sulfate. , 2001, Advances in carbohydrate chemistry and biochemistry.

[31]  R. Linhardt,et al.  Production and chemical processing of low molecular weight heparins. , 1999, Seminars in thrombosis and hemostasis.

[32]  Robert J. Linhardt,et al.  HEPARIN : AN IMPORTANT DRUG ENTERS ITS SEVENTH DECADE , 1991 .

[33]  A. Imbriano.  [Blood coagulation]. , 1955, La Semana medica.